Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
about
Protein kinase CK2 and human malignant tumorsFrom Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical ResearchrhEPO affects apoptosis in hippocampus of aging rats by upregulating SIRT1Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1.A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolismBig Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.Inhibition of casein kinase 2 blocks G2/M transition in early embryo mitosis but not in oocyte meiosis in mouseThe ways and means that fine tune Sirt1 activity.Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.Bioinformatics analysis of the serine and glycine pathway in cancer cellsResveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes.TAp73 promotes anabolismThe expression and correlation of SIRT1 and Phospho-SIRT1 in colorectal cancer.MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathwaySir2 phosphorylation through cAMP-PKA and CK2 signaling inhibits the lifespan extension activity of Sir2 in yeast.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.SIRT1: Regulator of p53 DeacetylationPPARγ regulated CIDEA affects pro-apoptotic responses in glioblastoma.The emerging and diverse roles of sirtuins in cancer: a clinical perspective.CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-cateninTargeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Targeting CK2-driven non-oncogene addiction in B-cell tumors.CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cells.TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.Network-based identification of key proteins involved in apoptosis and cell cycle regulation.Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapyTNFα regulates the localization of CD40 in lipid rafts of glioma cells.Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.Molecular dynamics of the full-length p53 monomer.Cancer-type dependent expression of CK2 transcripts.
P2860
Q27026335-B136BBED-0554-41DF-B3C9-7DCED8F44387Q28393309-9152D302-526A-4D7A-B809-CB38E9EDDE3BQ28566291-28FB2BF7-4B1D-4FBB-AFCE-8C20C4443B2FQ30559574-ECE6990A-22B5-409F-9A83-4E4632CB13BDQ33571714-5272A58B-7AA6-412B-B118-38B9311DCE22Q33720340-EC72999E-5F78-4516-BACF-A38E10F83C47Q33802553-653E84B1-4CCD-45E4-A353-746E6911F0C4Q33826714-CA132086-1D7C-4259-8B3C-27C8BF2C744BQ33914710-D8C6F8FA-A58A-40B3-8785-05F868A2EF8CQ34247901-E8F9B79F-BED2-4AF0-9C94-F33100C5D476Q34956789-A63B7305-D208-467C-BDAC-AEB1D4F8E76DQ35112888-1B8893A9-69AC-4CED-ADC3-4C3ACE9852E7Q35149652-BD9472D6-2D7B-4056-95D2-DB4ABEECD55DQ35173611-53BB8188-6C07-4397-9F52-3B946B4EC6F1Q35197507-A4DD0A92-D2B1-4205-84EC-56183D7A46C2Q35205600-D4A74157-745F-405F-92CB-642F11771B76Q36101389-80DECB59-3531-4A0C-9588-5EEE56A570F0Q36263671-51E29213-7F7B-4636-93EE-EDAF3F4E9ED8Q36285296-58A14EC9-49F1-4A28-B5F5-1D699192B02FQ36326939-36FFA8C3-9605-469B-8296-36C83B344173Q36544222-ACC5CC07-F868-4C6B-9908-29ECAC0E73ACQ36907054-5919080F-821D-44EA-BB0A-00C9EA3B063FQ36978377-B5C0B8EC-BE2F-42FD-8986-C0E50964ACD1Q37016599-3A7A93E0-CD08-4E50-BFB4-944E62B75E07Q37030289-C30646A8-24ED-44B8-AF74-36555DF77813Q37150526-F9455F29-E0EA-454B-9195-4AEC7A2F5E89Q37164423-79C01A60-8E5F-48E0-9EC5-3B45C30E7453Q37231067-2FB7AD6B-C68A-44BD-9FF8-0F634477B83BQ37619722-17C309DF-BC1C-41C0-9702-B8202754F6A3Q37731326-40860B7F-F53A-4E54-BE3E-DDF8CBA7943BQ38492153-E015E44F-9C8F-48D5-AFB1-50DB58E49216Q38797342-51CC3C0C-DF70-4B19-88DD-6F1322453FA0Q38832355-D5DB2C44-7B09-4C9A-A08A-467DEC3B9CF9Q38949348-87FDC44F-98FA-4729-9F75-09E723385DE4Q39181880-895E7A3A-20EE-41A3-A0E7-E7E13E774A72Q39201405-BE3653F4-2C40-486D-A80A-9D565ADDF178Q39331132-D4389D7A-E918-41C2-BD3F-321F14AA46FAQ42063067-978FC7CA-5696-46A2-BFE6-131206C503BEQ42103308-A036E8F6-318F-4778-ABB5-CE40A2660F54Q47114281-70F35B2C-C336-4A90-B972-8606E9FECAF4
P2860
Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@ast
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@en
type
label
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@ast
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@en
prefLabel
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@ast
Inhibition of Casein kinase-2 ...... osis through SIRT1 inhibition.
@en
P2093
P2860
P356
P1476
Inhibition of Casein kinase-2 ...... tosis through SIRT1 inhibition
@en
P2093
P2860
P356
10.1038/CDDIS.2012.10
P50
P577
2012-02-09T00:00:00Z